PANICHI, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 10.124
AS - Asia 5.307
EU - Europa 4.756
SA - Sud America 692
AF - Africa 245
Continente sconosciuto - Info sul continente non disponibili 111
OC - Oceania 18
Totale 21.253
Nazione #
US - Stati Uniti d'America 9.839
SG - Singapore 1.661
CN - Cina 1.514
PL - Polonia 1.274
IT - Italia 1.081
HK - Hong Kong 822
SE - Svezia 634
BR - Brasile 557
VN - Vietnam 429
BG - Bulgaria 321
DE - Germania 316
KR - Corea 260
CA - Canada 226
TR - Turchia 209
UA - Ucraina 202
FI - Finlandia 188
GB - Regno Unito 185
FR - Francia 164
RU - Federazione Russa 157
NG - Nigeria 107
CH - Svizzera 104
IN - India 93
JP - Giappone 62
AR - Argentina 54
BD - Bangladesh 42
IQ - Iraq 40
MX - Messico 27
SN - Senegal 27
CI - Costa d'Avorio 26
BE - Belgio 25
PK - Pakistan 24
NL - Olanda 22
EC - Ecuador 20
ID - Indonesia 18
VE - Venezuela 18
SA - Arabia Saudita 17
ZA - Sudafrica 16
AU - Australia 15
MA - Marocco 15
EG - Egitto 14
AT - Austria 13
CL - Cile 12
ES - Italia 12
KE - Kenya 12
PH - Filippine 12
UZ - Uzbekistan 12
CO - Colombia 11
UY - Uruguay 10
MY - Malesia 9
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
OM - Oman 8
TN - Tunisia 8
DZ - Algeria 7
JO - Giordania 7
LT - Lituania 7
AZ - Azerbaigian 6
GR - Grecia 6
HN - Honduras 6
IE - Irlanda 6
IR - Iran 6
JM - Giamaica 6
PY - Paraguay 6
RS - Serbia 6
TH - Thailandia 6
TW - Taiwan 6
IL - Israele 5
NP - Nepal 5
PT - Portogallo 5
ET - Etiopia 4
GT - Guatemala 4
RO - Romania 4
YE - Yemen 4
HU - Ungheria 3
KZ - Kazakistan 3
LV - Lettonia 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PA - Panama 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CR - Costa Rica 2
CY - Cipro 2
HR - Croazia 2
KG - Kirghizistan 2
LB - Libano 2
QA - Qatar 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
TG - Togo 2
AI - Anguilla 1
AL - Albania 1
BJ - Benin 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
Totale 21.126
Città #
Ashburn 1.017
Singapore 999
Hong Kong 801
Fairfield 734
Chandler 690
Santa Clara 641
San Jose 597
Woodbridge 589
Ann Arbor 537
Milan 486
Houston 468
Dallas 459
Sofia 320
Shanghai 310
Hefei 296
Seattle 290
Wilmington 286
Jacksonville 256
Seoul 252
Beijing 241
New York 231
Cambridge 216
Boardman 185
Ottawa 185
Princeton 158
Lawrence 145
Los Angeles 141
Council Bluffs 139
Medford 128
Izmir 124
Nanjing 115
Lauterbourg 111
Lagos 106
Ho Chi Minh City 88
Bern 83
Dong Ket 80
Hanoi 70
The Dalles 65
Columbus 63
Istanbul 59
Des Moines 55
Rome 55
Tokyo 54
Jüchen 51
Buffalo 49
Redondo Beach 48
Chicago 47
Helsinki 43
Nanchang 39
São Paulo 39
Dearborn 37
Frankfurt am Main 35
Ogden 34
Falls Church 33
Florence 33
San Diego 33
London 32
Munich 31
Boulder 29
Kunming 29
Hebei 28
Serra 28
Dakar 27
Abidjan 26
Lancaster 26
Nuremberg 23
Shenyang 21
Brussels 20
Norwalk 19
Baghdad 18
Changsha 18
Atlanta 17
Guangzhou 17
Pisa 17
Rio de Janeiro 17
Warsaw 17
Zurich 17
Belo Horizonte 16
Haiphong 16
Montreal 16
Jiaxing 15
Washington 14
Falkenstein 13
Pune 13
Redwood City 13
San Francisco 13
Tianjin 13
Chennai 12
Da Nang 12
Fuzhou 12
Turku 12
Boston 11
Cascina 11
Hangzhou 11
Mumbai 11
Orange 11
Orem 11
Ankara 10
Baltimore 10
Brasília 10
Totale 14.209
Nome #
Effect of simvastatin therapy on inflammatory markers and lipids in pre-dialysis patients 1.492
Correction to: Citrate high volume on-line hemodiafiltration modulates serum Interleukin-6 and Klotho levels: the multicenter randomized controlled study "Hephaestus" 311
C reactive protein in patients with chronic renal diseases 260
Extracellular Vesicles Derived from Endothelial Progenitor Cells Protect Human Glomerular Endothelial Cells and Podocytes from Complement- and Cytokine-Mediated Injury 212
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial 193
Caffeic acid, a phenol found in white wine, modulates endothelial nitric oxide production and protects from oxidative stress-associated endothelial cell injury 189
Biomarkers of chronic inflammatory state in uremia and cardiovascular disease. 186
Dimethylarginine levels and nutritional status in hemodialysis patients 184
RENAL EFFECTS OF ENALAPRIL IN HYPERTENSIVE PATIENTS WITH GLOMERULONEPHRITIS 183
Anti-aggregating activity of trans-and cis-resveratrol 182
Nitric oxide-dependent renal vasodilatation is not altered in rat with rHuEpo-induced hypertension. 182
Antiproteinuric effect of Losartan in patients with chronic renal diseases 181
Effect of increasing doses of lisinopril on proteinuria of normotensive patients with IgA nephropathy and normal renal function 180
Effect of a soy protein diet on serum lipids of renal transplant patients 180
Simvastatin (S) and fluvastatin (F) modulate cytokines production in isolated human monocytes from chronic renal failure patients 178
Effects on inflammatory and nutritional markers of haemodiafiltration with online regeneration of ultrafiltrate (HFR) vs online haemodiafiltration: a cross-over randomized multicentre trial 178
Effect of simvastatin therapy on inflammatory markers and lipids in pre-dialysis patients 175
LACK OF NOCTURNAL SERUM THYROTROPIN (TSH) SURGE IN PATIENTS WITH CHRONIC-RENAL-FAILURE UNDERGOING REGULAR MAINTENANCE HEMOFILTRATION - A CASE OF CENTRAL HYPOTHYROIDISM 175
Echocardiographyc ultrasonic tissue characterization in a case of l’abry’s disease following renal transplantation 174
Interleukin-8 is a powerful prognostic predictor of all-cause and cardiovascular mortality in dialytic patients 171
Soluble CD40 ligand is predictive of combined cardiovascular morbidity and mortality in patients on haemodialysis at a relatively short-term follow-up 170
Outcomes of vascular access care and surgery managed by interventional nephrologists: A twelve-year experience 168
Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study 168
Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: A pilot study 167
The biological response to online Hemodiafiltration 167
A VITAMIN E-COATED POLYSULFONE MEMBRANE REDUCES SERUM LEVELS OF INFLAMMATORY MARKERS AND ESAs RESISTANCE IN HAEMODIALYSIS PATIENTS: RESULTS FROM A RANDOMIZED CROSS-OVER MULTICENTRE TRIAL 167
RAASi Therapy Attenuates the Association between 24-h Urinary Potassium Excretion and Dietary Potassium Intake in CKD Patients 166
Vitamin D and Calcium Supplementation and Urolithiasis: A Controversial and Multifaceted Relationship 165
1,25-dihydroxyvitamin D-3 dose-dependently inhibits LPS-induced cytokines production in PBMC modulating intracellular calcium 165
MECHANISMS OF ACID-BASE HOMEOSTASIS IN ACETATE AND BICARBONATE DIALYSIS, LACTATE HEMOFILTRATION AND HEMODIAFILTRATION 163
Soy protein diet improves endothelial dysfunction in renal transplant patients 163
Iodine and thyroid dysfunction in uremia 162
Risk factors and action thresholds for the novel coronavirus pandemic. Insights from the Italian Society of Nephrology COVID-19 Survey 161
Neutralization of macrophage-stimulating protein ameliorates renal injury in anti-Thy 1 glomerulonephritis 159
Smell and Taste in Severe CoViD-19: Self-Reported vs. Testing 158
Acute CYA-induced ATP depletion is prevented by pretreatment with L-propionylcarnitine in isolated and perfused rat kidney 158
Painful neuropathy, monoclonal gammopathy and amyloid deposit: response to treatmente in 3 cases. 158
The Pisa experience of renal biopsies, 1977-2005 158
ULTRAFILTRATION - A RATIONAL TREATMENT FOR HEART-FAILURE 156
Efficacy and tolerability of manidipine in the treatment of hypertension in patients with non-diabetic chronic kidney disease without glomerular disease. Prospective, randomized, double-blind study of parallel groups in comparison with enalapril 156
Vascular calcifications as a footprint of increased calcium load and chronic inflammation in uremic patients: a need for a neutral calcium balance during hemodialysis? 153
An overview of haemodialysis and oxidant stress 153
Endothelial progenitor cell-derived extracellular vesicles protect from complement-mediated mesangial injury in experimental anti-Thy1.1 glomerulonephritis 150
Effect of simvastatin on plasma asymmetric dimethylarginine concentration in patients with chronic kidney disease 149
A Vitamin E-Coated Polysulfone Membrane Reduces Serum Levels of Inflammatory Markers and Resistance to Erythropoietin-Stimulating Agents in Hemodialysis Patients: Results of a Randomized Cross-Over Multicenter Trial 149
The link of biocompatibility to cytokine production 149
Biocompatibility evaluation of polyamide hemofiltration 149
PAIRED FILTRATION DIALYSIS (PFD) - BIOCOMPATIBILITY, DIALYTIC EFFICIENCY AND CLINICAL TOLERANCE IN A LONG-TERM MULTICENTER TRIAL 148
On-Line Hemodiafiltration in the Large RISCAVID Study 148
Theoretical calculation of optimal depth in the percutaneous native kidney biopsy to drastically reduce bleeding complications and sample inadequacy for histopathological diagnosis 148
Automatic Adaptive System Dialysis for Hemodialysis-Associated Hypotension and Intolerance: A Noncontrolled Multicenter Trial 145
Cytokine production in haemodiafiltration: a multicentre study 144
Renal transplantation in patients with Fabry disease 144
Nutritional knowledge in hemodialysis patients and nurses: focus on phosphorus. 144
Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients 143
The social cost of chronic kidney disease in Italy 143
Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy 143
Urotensin II is related with atherogenic risk in hemodialysis patients 142
C-reactive protein as a marker of chronic inflammation in uremic patients 142
Treatment of idiopathic membranous nephropathy (MNG) with high dose intravenous gammaglobulin: results of a multicenter non-randomized and non-controlled trial. 142
Mediterranean Dietary Pattern Adjusted for CKD Patients: The MedRen Diet 141
In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients 141
Economic impact of ferric carboxymaltose in haemodialysis patients 140
Treatment with 1,25-dihydroxyvitamin D3 preserves glomerular slit diaphragm-associated protein expression in experimental glomerulonephritis 140
Citrate anion improves chronic dialysis efficacy, reduces systemic inflammation and prevents Chemerin-mediated microvascular injury 139
Severe hypotension during hemofiltration in an uremic patient with metabolic alkalosis 139
C-reactive protein and interleukin-6 levels are related to renal function in predialytic chronic renal failure 139
1,25-Dihidroxyvitamin D3 dose-dependently inhibits LPS-induced cytokines production in PBMC modulating intracellular calcium 136
Oxidative stress and inflammatory reaction modulation by white wine 136
Protective effect of L-propionylcarnitine on cyclosporine-induced nephrotoxicity. 135
Online Hemodiafiltration Inhibits Inflammation-Related Endothelial Dysfunction and Vascular Calcification of Uremic Patients Modulating miR-223 Expression in Plasma Extracellular Vesicles 134
Divert to ULTRA: Differences in infused volumes and clearance in two on-line hemodiafiltration treatments 134
Echocardiographic ultrasonic tissue characterization in a case of Fabry's disease following renal transplantation 134
Impact of calcium, phosphate, PTH abnormalities and management on mortality in hemodialysis: results from the RISCAVID study 134
Geriatric nutritional risk index is a strong predictor of mortality in hemodialysis patients: data from the Riscavid cohort. 134
Pure red cell aplasia induced by epoetin zeta 133
C-reactive protein and interleukin 6 are related to renal function in chronic renal failure 133
Study of serum 3,5,3'-triiodothyronine sulfate concentration in patients with systemic non-thyroidal illness 133
INTRAVENOUS IMMUNOGLOBULIN THERAPY OF MEMBRANOUS NEPHROPATHY - EFFICACY AND SAFETY 131
Effects of 1,25(OH)(2)D-3 in experimental mesangial proliferative nephritis in rats 131
Protective effect of L-propionylcarnitine in chronic cyclosporine-a induced nephrotoxicity 131
EFFECT OF INCREASING DOSES OF LISINOPRIL ON PROTEINURIA OF NORMOTENSIVE PATIENTS WITH IGA NEPHROPATHY AND NORMAL RENAL-FUNCTION 130
Inflammation, CRP, calcium overload and a high calcium-phosphate product: a 'liaison dangereuse' 130
Results from the RISCAVID study: is haemodiafiltration associated with improved survival? Reply 130
Plasma C-reactive protein in haemodialysis 130
Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study 130
CELLULAR EXPRESSION OF LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 AND INTERCELLULAR-ADHESION MOLECULE-1 IN NORMAL KIDNEY STRUCTURES AND IN RENAL-CANCER - POSSIBLE SIGNIFICANCE IN IMMUNE-RESPONSE AND IN THE CLINICOPATHOLOGICAL CORRELATION 129
Plasma C-reactive protein in hemodialysis patients: A cross-sectional, longitudinal clinical survey 128
Acute suppression of parathyroid activity during hemofiltration 128
Protein layer on hemodialysis membranes: a new immunohistochemistry technique. 128
Ultrasonic tissue characterization (backscatter) in the analysis of left ventricular myocardial intrinsic function in systemic amyloidosis 127
Effects of calcitriol on the immune system: New possibilities in the treatment of glomerulonephritis 127
Citrate high volume on-line hemodiafiltration modulates serum Interleukin-6 and Klotho levels: the multicenter randomized controlled study "Hephaestus" 122
Plasma C-reactive protein is linked to backfiltration associated interleukin-6 production 122
Ultrasonic Myocardial Texture Parameters in Hemodialytic Patients Compared withEssential Hypertensive Patients. 1st International Congress on Heart Disease – New Trends in Research, Diagnosis and Treatment. Washington DC, USA, May 16-19, 1999. 122
ABCs of hemodiafiltration prescription: The Pisa style 121
Ochratoxin A-induced renal cortex fibrosis and epithelial-to-mesenchymal transition: Molecular mechanisms of ochratoxin A-injury and potential effects of red wine 121
Efficacy, Safety and Pharmacoeconomic Analysis of Intravenous Ferric Carboxymaltose in Anemic Hemodialysis Patients Unresponsive to Ferric Gluconate Treatment: A Multicenter Retrospective Study 119
ACUTE-RENAL-FAILURE AFTER MEZLOCILLINE 119
C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes 118
Totale 16.578
Categoria #
all - tutte 61.300
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.300


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.326 0 76 14 95 265 180 20 74 86 27 53 436
2022/20231.808 263 221 97 172 316 211 25 137 240 7 106 13
2023/20242.813 242 210 225 127 256 224 29 27 18 1.278 38 139
2024/20254.476 14 169 22 232 468 482 426 275 393 611 522 862
2025/20264.912 345 684 531 330 467 483 903 307 283 310 175 94
2026/2027338 134 204 0 0 0 0 0 0 0 0 0 0
Totale 21.253